depression

Wondermed pulls $4,600K out of a hole to ply you with ketamine

For those of us who’ve been a little bit wobbly on the mental health front over the past couple of years, there are a bunch of options starting to crop up. The on-demand chat-based therapy optio

Depressed? This algorithm can tell from the tone of your voice

Mental health issues have come into a clearer focus amid the pandemic. Depression became endemic, but it still too often goes undetected. Even when it does, healthcare providers struggle to meet deman

6 questions investors should ask when evaluating psychedelic biotech companies

We believe in a future where psychedelic therapy will be as common as going to the dentist, but the path won’t be easy.

Inflow, a science-based app for ADHD, raises $2.3M Seed led by Hoxton Ventures

Attention deficit hyperactivity disorder (ADHD) symptoms can include anxiety, chronic boredom, impulsiveness, trouble concentrating, controlling anger, and even depression. But ADHD sufferers can face

How Cerebral and Alto Neuroscience embarked on an at-home clinical trial for depression

Before the pandemic forced remote work, school and research to the forefront, decentralized clinical trials were probably on the horizon. Now, they’re here in earnest.  This week, precision psychia

A look inside Offline Ventures, co-founded by Brit and Dave Morin and backed in part by Apple

Last year, entrepreneurs, investors and married couple Dave and Brit Morin teamed up with James Higa, who was a senior director at Apple for nearly a dozen years, and Tonal co-founder Nate Bosshard, t

Journey Clinical raises $3M to allow psychotherapists to offer psychedelic therapies

Psychedelics companies are all the rage right now. Compass Pathways is working with the magic mushroom compound psilocybin to treat depression. It’s has raised $290 million in total. Atai Life Scien

Ro raises $500M to grow its remote and in-home primary care platform

Healthcare tech startup Ro has raised $500 million to help fuel continued growth of its hybrid telehealth/in-home primary care platform, which also includes a growing pharmacy business as the company

Alphabet’s X details Project Amber, a quest for a single biomarker for depression that fell short of its goal

Alphabet’s X (the Google-owner’s so-called “Moonshot Factory”) published a new blog post today about Project Amber, a project it’s been working on over the past three yea

Ro makes the weight loss product Plenity commercially available to everyone in the US

In what could be the first step in the development of a significant new line of business for the telemedicine prescription provider Ro, the company is finally announcing the general commercial availab

Five success factors for behavioral health startups

We believe there’s an enormous opportunity to digitize behavioral health right now—and COVID-19 is only making it bigger.

Ahead, a platform that connects psychiatrists with patients, raises $9 million

In 2015, Andy Rink debuted Lully at a Y Combinator demo day. The product was meant to help children overcome night terrors. Lully had plans to launch into new markets, such as bed wetting, but clinica

Tia gets over $24 million to build a network of holistic health clinics and virtual services for women

Tia, the developer of a network of digital wellness apps, clinics and telehealth services designed to treat women’s health holistically, has raised $24.275 million in a new round of funding. The

Lucid Lane has developed a service to get patients off of pain meds and avoid dependence

Four years ago, Adnan Asar, the founder of the new dependence prevention service Lucid Lane, was enjoying a successful career working as the founding chief technology officer at Livongo Health. It was

Hims launches group therapy services as first foray into broader mental health initiative

Hims, the startup consumer health brand providing out-of-pocket physician services online, has launched group therapy services through its Hims and Hers brands as part of an initial push into mental h

Risks and rewards of digital therapeutics in treating mental disorders

More Americans than ever before are suffering from mental and emotional distress. Because the resources for those living with mental health issues are constrained, startups could have a big impact.

As researchers pursue links between bacteria and human health, startups stand to benefit

In 2009, the National Institutes of Health launched a five-year, $150 million project to stimulate research into a new field of medicine examining the connections between the millions of bacteria livi

FDA approves esketamine nasal spray, the first new major depression drug in more than 30 years

In one of the most significant milestones for depression treatment in decades, the U.S. Food and Drug Administration announced today that it has approved a new drug with esketamine, a derivative of ke

Limiting social media use reduced loneliness and depression in new experiment

The idea that social media can be harmful to our mental and emotional well-being is not a new one, but little has been done by researchers to directly measure the effect; surveys and correlative studi

MIT researchers teach a neural network to recognize depression

A new technology by MIT researchers can sense depression by analyzing the written and spoken responses by a patient. The system, pioneered by MIT’s CSAIL group, uses “a neural-network mode
Load More